Keywords: valeant, sells, hep, drug, rivers, million, plus

Valeant sells hep C drug to Three Rivers for $70.8 million plus

Article | 07 January 2008

Print This

Valeant Pharmaceuticals International has signed a definitive agreement to divest the US and Canadian rights to the hepatitis C drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in